Related Experiment Videos
[Mass ciguatera poisoning after eating barracuda in Mexico: prognostic and therapeutic implications]
L De Haro1, M Hayek-Lanthois, F Joossen
1Centre Anti-poisons, Hôpital Salvator, Marseille, France.
Abstract:
Thirty patients were admitted to the Anti-Poison Center of Marseille, France, on the fifth day of ciguatera fish poisoning due to ingestion of the same barracuda in Mexico. The purpose of this prospective study conducted during management of this group was to identify prognostic factors and evaluate the efficacy of treatment using mannitol. Upon admission severity was individually scored based on clinical findings. Twenty-two patients exhibiting the highest severity scores were immediately treated by infusion of 250 ml of 20% mannitol within one hour. These patients presented low plasma cholinesterase levels. Treatment led to transient improvement mainly with regard to cramping and digestive manifestations. All patients who presented high severity scores upon admission reported persistent manifestations lasting between 1 and 7 months. In 6 of these patients symptoms recurred after ingestion of seafood and/or alcohol. The fact that the extent of clinical symptoms in terms of severity and duration was correlated with the amount of fish ingested confirms that ciguatera poisoning is dose-dependent in man. However cholinesterase levels were not correlated with the severity of clinical manifestations.
Insights
Ciguatera fish poisoning severity and duration correlate with fish intake. Mannitol treatment offered only transient relief for severe cases of this marine toxin illness.
Area of Science:
- Marine toxicology
- Neurotoxicology
- Environmental health
Context:
- Ciguatera fish poisoning (CFP) is a significant marine neurotoxic illness.
- Outbreaks can result from consuming contaminated fish, posing public health challenges.
- Understanding CFP's clinical course and treatment efficacy is crucial for patient management.
Purpose:
- To identify prognostic factors in CFP.
- To evaluate the therapeutic efficacy of mannitol in managing CFP.
- To explore the dose-dependent nature of CFP in humans.
Summary:
- A prospective study involved 30 patients with CFP from barracuda ingestion, admitted to the Anti-Poison Center of Marseille.
- High-severity patients received mannitol infusions, showing transient improvement in cramping and digestive symptoms.
- Persistent symptoms (1-7 months) and seafood/alcohol-triggered recurrences were observed in severe cases, indicating CFP is dose-dependent.
Impact:
- CFP severity and duration are linked to the amount of toxic fish consumed.
- Mannitol provided only temporary symptom relief, highlighting the need for further therapeutic strategies.
- Cholinesterase levels did not correlate with clinical manifestation severity in this CFP cohort.